FIELD: chemistry, pharmaceutics.
SUBSTANCE: claimed invention relates to novel compounds of formula (I) and their pharmaceutically acceptable salts. Compounds of claimed invention possess properties of agonists of mGlu 1 receptors and can find application in treatment of such diseases as psychosis, schizophrenia, Alzheimer's disease, etc. In general formula (I) one of R1 and R2 stands for trifluoromethyl, the other stands for hydrogen; R3, R3' independently on each other stand for hydrogen or halogen.
EFFECT: obtaining medication which possesses properties of agonists of mGlu 1 receptors.
7 cl, 2 tbl, 2 dwg, 17 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF CARBAMIC ACID ESTERS, THEIR PREPARING (VARIANTS) AND THEIR APPLYING AS LIGANDS OF METABOTROPIC GLUTAMATE RECEPTORS | 2000 |
|
RU2248349C2 |
BENZOTHIAZOLE DERIVATIVES | 2001 |
|
RU2251419C2 |
DERIVATIVES OF DIHYDROBENZO[b][1,4]DIAZEPINE-2-ONE AS I mGluR2 ANTAGONISTS | 2002 |
|
RU2270197C2 |
DERIVATIVES OF PYRIDINE AND MEDICINAL AGENT BASED ON THEREOF POSSESSING SELECTIVE BLOCKING ACTIVITY WITH RESPECT TO SUBSPECIES OF NMDA-RECEPTORS | 2002 |
|
RU2303037C2 |
PYRIDINE-2-CARBOXAMIDE DERIVATIVES AS mGluR5 ANTAGONISTS | 2006 |
|
RU2411237C2 |
DERIVATIVES OF DIHYDROBENZO[b][1,4]DIAZEPINE-2-ONE AS ANTAGONISTS OF MGLUR2 II | 2002 |
|
RU2263112C2 |
DERIVATIVES OF QUINUCLIDINEAMIDE, METHOD FOR THEIR PREPARING AND THEIR USING, PHARMACEUTICAL COMPOSITION, COMBINED PRODUCT AND METHOD FOR INHIBITION OF MUSCARINIC RECEPTORS | 2003 |
|
RU2314306C2 |
DERIVATIVES OF SULFONYLPYRROLIDINE | 2001 |
|
RU2272026C2 |
BENZOCYCLOALKYLAZOLOTHIONE DERIVATIVES | 1995 |
|
RU2145321C1 |
DERIVATIVES OF BENZODIAZEPINE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2001 |
|
RU2278865C2 |
Authors
Dates
2009-01-27—Published
2003-12-17—Filed